Adam Maeder, an analyst from Piper Sandler, has initiated a new Hold rating on Resmed (RMD).Stay Ahead of the Market:Discover outperforming ...

Goldman Sachs initiated coverage on ResMed Inc (NYSE:RMD) with a "Buy" rating and a price target of A$48.9, driven by strong growth prospects in its continuous airway pressure (CPAP) therapy segment.

Goldman Sachs initiated coverage of ResMed (RMD) with a Buy rating and A$48.90 price target The firm says its Buy thesis is based on “robust” ...

Investing.com -- Goldman Sachs initiated coverage on ResMed Inc (NYSE ... strong growth prospects in its continuous airway pressure (CPAP) therapy segment.

After that inflation report was released, mortgage rates began to tick back up, climbing from an average of 6.75% in mid-December to over 7% by month's end. This new inflation data could push ...

Mortgage rates have popped back up to near 7% — 6.91% was the average reported by Freddie Mac last week. Mortgage rates have been rising on expectations that the Federal Reserve will keep ...

A new year will mean a new, slightly higher standard mileage rate for 2025. The Internal Revenue Service on Thursday announced that the 2025 standard mileage rate will go up by 3 cents per mile to ...

Traders now see the Federal Reserve continuing its rate-easing cycle later in 2025 after the December nonfarm payrolls report blasted past expectations. Pricing in fed funds futures suggest the ...

High pneumothorax rates have been reported in term neonates receiving continuous positive airway pressure (CPAP) in the delivery room. Researchers conducted a retrospective study to evaluate if ...

Mortgage rates ended 2024 with a bang – but not the kind that’s good for borrowers. And for anyone in the market for a home – or a refinance – 2025 may not be much kinder. In the week ...

Investopedia / Photo Illustration by Alice Morgan / Getty Images The Federal Reserve expects to cut its influential federal funds rate at a slower pace in the new year than previously anticipated.